Omnicell (OMCL) Tops Q4 EPS by 2c ; Offers Guidance

Omnicell (NASDAQ: OMCL) reported Q4 EPS of $0.60, $0.02 better than the analyst estimate of $0.58. Revenue for the quarter came in at $306.88 million versus the consensus estimate of $299.6 million.

GUIDANCE:

Omnicell sees Q1 2025 EPS of $0.15-$0.25, versus the consensus of $0.31. Omnicell sees Q1 2025 revenue of $255-265 million, versus the consensus of $264.9 million.

Omnicell sees FY2025 EPS of $1.65-$1.85, versus the consensus of $1.69. Omnicell sees FY2025 revenue of $1.1-1.15 billion, versus the consensus of $1.15 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• MAIA Biotechnology (MAIA) files $150M mixed shelf
• Adient amends credit deal, adds $500M in incremental term loans